Apogee Therapeutics Inc
APGEHealthcare|Biotechnology|USA
$133.65
+0.08 (+0.06%)
Tangible Book
$16.77
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (61)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| HENDERSON MICHAEL THOMAS | CEO | 2026-07-08 | SELL | 20,000 | $133.63 | $2672.6K |
| Dambkowski Carl | Chief Medical Officer | 2026-07-01 | SELL | 5,500 | $132.74 | $730.1K |
| Dambkowski Carl | Chief Medical Officer | 2026-06-22 | SELL | 26,400 | $132.6 | $3500.6K |
| HENDERSON MICHAEL THOMAS | CEO | 2026-06-22 | SELL | 80,000 | $132.54 | $10603.2K |
| HENDERSON MICHAEL THOMAS | CEO | 2026-06-10 | SELL | 20,000 | $83.38 | $1667.6K |
| Dambkowski Carl | Chief Medical Officer | 2026-06-03 | SELL | 5,500 | $78.71 | $432.9K |
| HENDERSON MICHAEL THOMAS | CEO | 2026-05-13 | SELL | 20,000 | $82.09 | $1641.8K |
| Dambkowski Carl | Chief Medical Officer | 2026-05-06 | SELL | 5,500 | $84.14 | $462.8K |
| Henderson Jane | CFO | 2026-05-01 | SELL | 2,000 | $82.04 | $164.1K |
| Henderson Jane | CFO | 2026-04-16 | SELL | 2,000 | $90 | $180K |
| Dambkowski Carl | Chief Medical Officer | 2026-04-01 | SELL | 5,500 | $84.84 | $466.6K |
| Henderson Jane | CFO | 2026-04-01 | SELL | 2,000 | $85.01 | $170K |
| Henderson Jane | CFO | 2026-03-25 | SELL | 2,000 | $85 | $170K |
| HENDERSON MICHAEL THOMAS | CEO | 2026-03-11 | SELL | 20,000 | $74.78 | $1495.6K |
| Dambkowski Carl | Chief Medical Officer | 2026-03-04 | SELL | 5,500 | $71.06 | $390.8K |
| Henderson Jane | CFO | 2026-03-02 | SELL | 2,000 | $70.22 | $140.4K |
| HENDERSON MICHAEL THOMAS | CEO | 2026-02-11 | SELL | 20,000 | $63.35 | $1267K |
| Dambkowski Carl | Chief Medical Officer | 2026-02-04 | SELL | 5,500 | $65.79 | $361.8K |
| Henderson Jane | CFO | 2026-02-02 | SELL | 2,000 | $65.81 | $131.6K |
| Fairmount Healthcare Fund II L.P. | Director | 2026-01-22 | SELL | 1,750,000 | $76.3 | $133525K |
| HENDERSON MICHAEL THOMAS | CEO | 2026-01-14 | SELL | 20,000 | $81.11 | $1622.2K |
| Dambkowski Carl | Chief Medical Officer | 2026-01-07 | SELL | 18,700 | $77.84 | $1455.6K |
| Henderson Jane | CFO | 2026-01-06 | SELL | 8,000 | $76.14 | $609.1K |
| Henderson Jane | CFO | 2025-12-19 | SELL | 1,500 | $80 | $120K |
| HENDERSON MICHAEL THOMAS | CEO | 2025-12-10 | SELL | 20,000 | $75.38 | $1507.6K |
| Henderson Jane | CFO | 2025-12-04 | SELL | 1,500 | $75 | $112.5K |
| HENDERSON MICHAEL THOMAS | CEO | 2025-12-04 | SELL | 40,000 | $75.01 | $3000.4K |
| Dambkowski Carl | Chief Medical Officer | 2025-12-04 | SELL | 10,900 | $75 | $817.5K |
| Henderson Jane | CFO | 2025-11-25 | SELL | 1,500 | $70 | $105K |
| Henderson Jane | CFO | 2025-11-14 | SELL | 2,000 | $65 | $130K |
| HENDERSON MICHAEL THOMAS | CEO | 2025-11-13 | SELL | 20,000 | $63.01 | $1260.2K |
| Henderson Jane | CFO | 2025-11-11 | SELL | 1,000 | $60 | $60K |
| Dambkowski Carl | Chief Medical Officer | 2025-11-05 | SELL | 10,785 | $55.07 | $593.9K |
| Dambkowski Carl | Chief Medical Officer | 2025-10-01 | SELL | 5,110 | $39.8 | $203.4K |
| Dambkowski Carl | Chief Medical Officer | 2025-09-03 | SELL | 2,725 | $37.87 | $103.2K |
| Dambkowski Carl | Chief Medical Officer | 2025-08-06 | SELL | 2,725 | $37.78 | $103K |
| Dambkowski Carl | Chief Medical Officer | 2025-07-02 | SELL | 10,090 | $45.09 | $455K |
| Dambkowski Carl | Chief Medical Officer | 2025-06-04 | SELL | 2,725 | $36.96 | $100.7K |
| Dambkowski Carl | Chief Medical Officer | 2025-05-07 | SELL | 2,725 | $35.75 | $97.4K |
| Dambkowski Carl | Chief Medical Officer | 2025-04-02 | SELL | 3,860 | $36.22 | $139.8K |
| Dambkowski Carl | Chief Medical Officer | 2025-02-05 | SELL | 3,520 | $40.69 | $143.2K |
| HENDERSON MICHAEL THOMAS | CEO | 2025-02-05 | SELL | 15,000 | $40.58 | $608.7K |
| HENDERSON MICHAEL THOMAS | CEO | 2025-01-08 | SELL | 15,000 | $48.85 | $732.8K |
| Dambkowski Carl | Chief Medical Officer | 2025-01-02 | SELL | 4,085 | $46.94 | $191.7K |
| McKenna Mark C. | Director | 2024-12-12 | BUY | 20,000 | $49.54 | $990.8K |
| Dambkowski Carl | Chief Medical Officer | 2024-12-11 | SELL | 4,540 | $48.76 | $221.4K |
| Dambkowski Carl | Chief Medical Officer | 2024-12-04 | SELL | 6,665 | $46.07 | $307.1K |
| HENDERSON MICHAEL THOMAS | CEO | 2024-12-04 | SELL | 15,000 | $46.58 | $698.7K |
| Dambkowski Carl | Chief Medical Officer | 2024-11-06 | SELL | 6,665 | $59.12 | $394K |
| HENDERSON MICHAEL THOMAS | CEO | 2024-11-06 | SELL | 15,000 | $59.22 | $888.3K |
| Dambkowski Carl | Chief Medical Officer | 2024-10-02 | SELL | 6,665 | $56.26 | $375K |
| HENDERSON MICHAEL THOMAS | CEO | 2024-10-02 | SELL | 40,000 | $56.23 | $2249.2K |
| HENDERSON MICHAEL THOMAS | CEO | 2024-09-04 | SELL | 40,000 | $47.62 | $1904.8K |
| Dambkowski Carl | Chief Medical Officer | 2024-09-04 | SELL | 6,665 | $47.56 | $317K |
| Henderson Jane | CFO | 2024-08-23 | SELL | 6,000 | $48.26 | $289.6K |
| Dambkowski Carl | Chief Medical Officer | 2024-08-07 | SELL | 7,335 | $40.67 | $298.3K |
| HENDERSON MICHAEL THOMAS | CEO | 2024-08-07 | SELL | 40,000 | $40.62 | $1624.8K |
| HENDERSON MICHAEL THOMAS | CEO | 2024-07-05 | SELL | 15,000 | $37.26 | $558.9K |
| Dambkowski Carl | Chief Medical Officer | 2024-07-03 | SELL | 5,995 | $37.6 | $225.4K |
| Shah Nimish P | Director | 2023-07-13 | BUY | 1,750,000 | $17 | $29750K |
| Fairmount Healthcare Fund L.P. | Director | 2023-07-13 | BUY | 2,941,176 | $17 | $50000K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked